期刊文献+

强骨饮对去势大鼠股骨颈骨形态计量学的影响 被引量:9

Effect of Chinese herbal medicine (Qiangguyin) on histomorphology of femur neck in ovariectomized rats
下载PDF
导出
摘要 目的探讨中药强骨饮对去势大鼠骨形态计量学的影响。方法选择雌性SD大鼠60只,随机分为强骨饮组(治疗组)、仙灵骨葆组(对照组)和空白对照组,切除大鼠卵巢2月后,给予中药强骨饮灌胃治疗,并与仙灵骨葆组和空白对照组对照治疗,后分别于3月、4.5月、6月取股骨颈包埋切片,全自动图像分析及骨形态计量学软件处理,观察中药对骨形态计量学参数的影响。结果卵巢切除后大鼠骨小梁面积百分数(%Tb.Ar)下降,骨小梁数量(Tb.N)下降,骨小梁宽度(Tb.Th)下降,经强骨饮治疗3月、4.5月、6月后,与空白对照组比较,Tb.Th差异具有显著性(P<0.01)、与仙灵骨葆组比较,Tb.N差异具有显著性(P<0.05)。结论中药强骨饮具有增加骨量,提高骨质量的作用,说明中药强骨饮对骨质疏松有明显的治疗作用。 Objective To explore the histomorphology effect of Qiangguyin on ovariectomized rats. Methods Sixty female SD rats were divided randomly into three groups: Qiangguyin group( treatment group).Xianlinggubao group (contrast group) and control group. All rats were ovariectomized, the Qiangguyin group.Xianlinggubao group and control group were given Qiangguyin .Xianlinggubao and distilled water after two weeks respectively. And 3,4. 5,6 months after the treatment, the femur neck were cut and stained with Massen Golden Trichrome for bone histomorphometric analysis. Results The Tb. Ar.Tb.N.Tb.Th of ovariectomized rats were decreased. Compared with Tb.Th of control group (P 〈 0.01) and rib. N of Xianlinggubao group( P 〈 0.05), the differences were observed. Conclusions Chinese herbal medicine (Qiangguyin) can increase the bone quantity and quality. Qiangguyin is effective in treatment of osteoporosis.
出处 《中国骨质疏松杂志》 CAS CSCD 2007年第6期433-435,共3页 Chinese Journal of Osteoporosis
关键词 中药 卵巢切除术 骨组织形态计量学 骨质疏松症 Chinese herbal medicine Ovariectomy Histomorphometry Ostroporosis
  • 相关文献

参考文献8

  • 1NIH Consensus.Development Fanel on Osteoporosis Prevention Diagnosis and Therapy.JAMA,2001,285:785.
  • 2FDA:Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporsis(Draft).1994.
  • 3Ott SM,Oleksik A,Lu Y,et al.Bone histomorphometric and biochemical marker results of a 22-year placebo-controlled trial of raloxifene in postmenopausal women.J Bone Miner Res,2002,17(2):341-348.
  • 4邱明才.骨质疏松研究的现状与展望[J].中华医学杂志,2001,81(14):833-835. 被引量:102
  • 5Barger Lux MJ,Recker RR.Bone microstucture in osteoporosis:transilia biopsy and histomorphometry.Top Magn Reson Imaing,2002,13(5):297-305.
  • 6George AC,Murrel MB,Martin M,et al.Nitricoxide:an important articular free radical.Bone Joint Surg,1996,78:265-273.
  • 7Chambers TJ,Chow JW,Lean JM.The anabolic action of estrogenon rat bone.In:Sex steroid and bone,Berlin:Springer,1994:119.
  • 8李恩,孔德娟,杨学辉,刘素彩,支会英,李芳芳,刘和娣.补肾方药对骨质疏松防治的实验研究[J].中国骨质疏松杂志,2002,8(2):166-170. 被引量:70

二级参考文献8

  • 1[1]Notelovitz M.Estrogen therapy and osteoporosis:principles and paractice.Am J Med Sci.1997,313:2-12.
  • 2[2]Licata AA.Bisphosphonate therapy.Am J Med Sci.1997,313:17-22.
  • 3[3]Lynch MP,Stein JL,Stein GS et al.The influence of collagen type Ⅰ on the development and maintenance of the osteoblasts phenotype in primary and passaged rat calvarial osteoblasts:modification of expression gene supporting cell growth,adhesion and extracellular matrix mineralization.Exp Cell Res,1995,216(1):35-45.
  • 4[4]Scott DB,Liu YS,Hair GA,et al.LMP-1,A LIM-domain protein,mediates BMP-6 effects on bone formation.Endocrinology,1998,139:5125-5134.
  • 5[5]Kim CH,Cheng SL,Kim GS.Effects of dexamethasone on proliferation,activity and cytokine secretion of normal human bone marrow stromal cells: possible mechanism of glucocorticoid-induced bone loss.J Endocrinol,1999,162:371-379.
  • 6[6]Watts NB.Clinical utility of biochemical markers of bone remodeling.Clin Chem,1999,45:1359-1368.
  • 7[7]Agnusdei D,Camporeale A,Zacchei F,et al.Effects of ipriflavone on bone mass and bone remodeling in patients with established postemeopausal osteoporosis.Curr Therap Res,1992,51:82-91.
  • 8[8]Benvenuti S,Tanini A,Frediani U,et al.Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.J Bone Miner Res,1991,6:987-994.

共引文献168

同被引文献107

引证文献9

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部